JPS6338190B2 - - Google Patents
Info
- Publication number
- JPS6338190B2 JPS6338190B2 JP60112285A JP11228585A JPS6338190B2 JP S6338190 B2 JPS6338190 B2 JP S6338190B2 JP 60112285 A JP60112285 A JP 60112285A JP 11228585 A JP11228585 A JP 11228585A JP S6338190 B2 JPS6338190 B2 JP S6338190B2
- Authority
- JP
- Japan
- Prior art keywords
- medium
- cells
- glutamine
- heat
- sterilized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 210000004102 animal cell Anatomy 0.000 claims description 8
- 238000012258 culturing Methods 0.000 claims description 6
- 108010016626 Dipeptides Proteins 0.000 claims description 5
- 150000008575 L-amino acids Chemical group 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 21
- 239000002609 medium Substances 0.000 description 19
- 230000001954 sterilising effect Effects 0.000 description 10
- 238000004659 sterilization and disinfection Methods 0.000 description 10
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 229930182816 L-glutamine Natural products 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 150000008540 L-glutamines Chemical class 0.000 description 3
- 239000012980 RPMI-1640 medium Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 229950010030 dl-alanine Drugs 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012533 medium component Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- PNMUAGGSDZXTHX-BYPYZUCNSA-N Gly-Gln Chemical compound NCC(=O)N[C@H](C(O)=O)CCC(N)=O PNMUAGGSDZXTHX-BYPYZUCNSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- KSMRODHGGIIXDV-YFKPBYRVSA-N N-acetyl-L-glutamine Chemical compound CC(=O)N[C@H](C(O)=O)CCC(N)=O KSMRODHGGIIXDV-YFKPBYRVSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 229960002648 alanylglutamine Drugs 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 108010010147 glycylglutamine Proteins 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 238000012007 large scale cell culture Methods 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 239000004017 serum-free culture medium Substances 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Description
〔産業上の利用分野〕
本発明は、動物細胞を培養するための培地に関
する。
〔従来の技術〕
動物、特にヒト細胞を培養して、その培養上清
液もしくは細胞から、有用な生理活性物質を得る
ことを目的とした研究が活発化しており、特にイ
ンターフエロン(IFN)やモノクロナール抗体の
開発については、癌の予防、治療への可能性を秘
めていることからその進捗には著しいものがあ
る。しかしながら、細胞培養上精液から生理活性
物質を大量に得、それを精製して利用するために
は技術的に大きな問題がある。
その一つに、培地をメンブラン・フイルターな
どのフイルターを用いて濾過滅菌しなければなら
ないという問題がある。この濾過滅菌法では通常
0.2ないし0.5mμのポアサイズをもつフイルター
を使うが、この濾過法ではバクテリアより小さな
微生物、例えば動物細胞の培養において障害をも
たらすことが知られているマイコプラズマ、ウイ
ルスなどは除去することが、困難である。また、
濾過滅菌は、フイルターを加圧または減圧下で行
わなければならず、フイルターの材質によつて
は、培地の微量有効成分が吸着して失なわれた
り、膜にかかる圧力や材質の不均一性のために、
微量の細菌が漏出することも稀にみられるので、
濾過滅菌して調製した培地は各種の検定をしなけ
ればならない。特に大量細胞培養では上記の問題
点は深刻で、さらに膜や装置のランニングコスト
も大きくなる。
これらの問題を解決するためには加熱殺菌すれ
ばよい。これまでに加熱殺菌し得る培地の調製方
法として、PHが4.0ないし4.5でオートクレーブ殺
菌し得る培地の調製方法が知られている(Proc.
Soc.EXp.Biol.Med.、127巻335頁1968年)。しか
しながら、これらの培地では、L−グルタミンと
重炭酸ナトリウムが加熱殺菌できず、依然として
L−グルタミンは濾過滅菌する必要があつた。
加熱に対して安定なL−アラニル−L−グルタ
ミン等のL−グルタミン誘導体が知られている
が、(J.Appl.Biochem.4巻、280頁、1982年)、動
物細胞にL−グルタミンとして利用されるかどう
か不明であつた。
〔発明が解決しようとする問題点〕
従つてこの発明の目的は、加熱に対して安定で
あり、かつ動物細胞にL−グルタミンとして利用
されるL−グルタミン誘導体を見い出し、これに
よつて加熱殺菌することができる動物細胞用培地
を見出すことにある。
〔問題点を解決するための手段〕
叙上のような状況下において本発明者らは、X
−L−グルタミン(XはL−アミノ酸である)で
あらわされるジペプチドの水溶液をオートクレー
ブ殺菌して調製した培地が、動物細胞の培養に好
適であることを見出した。
本発明の培地は、弱酸性で加熱殺菌できる培
地、例えばEagle MEM培地、ダルベツコMEN
培地、RPMI1640培地及びこれらの混合培地など
より重炭酸ナトリウムとL−グルタミンを除き、
かつX−L−グルミタンを添加したものである。
これらの培地として、血清または血清代替物と
しての各種増殖因子を含む血清添加培地又は無血
清培地も含まれる。
本発明のX−L−グルタミンであらわされるジ
ペプチドのXは、グリシン、L又はDL−アラニ
ン、L−アスパラギン酸、L−グルタミン酸、L
−バリン、L−ロイシン、L−セリン、L−リジ
ン、L−フエニルアラニンなどであるが、その原
料価格の点からグリシン、L又はDL−アラニン
が好適である。
本発明において用いられる動物細胞としては、
例えばWI−38、HeLa、L、UMCL、BALL−
1、X−5563、Molt−4、末梢血リンパ球、各
種ハイブリドーマ等があげられる。
X−L−グルタミンは、本来、添加すべきL−
グルタミンと同モル濃度(1から4mM)となる
ように溶解し、通常の加熱殺菌(120℃、20分)
を行なうのがよい。また、X−L−グルタミンの
みをその添加濃度の100から500倍の水溶液とし、
加熱殺菌した後培養液にその1/100から1/500量を
添加して調製することもできる。
このように調製した培地に10%の重炭酸ナトリ
ウム水溶液を加熱殺菌後培地中所定量となるよう
に添加することによつて全ての低分子培地成分を
加熱殺菌によつて調製できる。
〔発明の効果.作用〕
この発明の動物細胞培養用培地は、総ての低分
子培地成分が加熱殺菌できる点で勝れている。
さらに培地を長期間保存できるという利点があ
る。
また、本発明によるX−L−グルタミンのX
は、細胞の要求性に合わせたアミノ酸を選ぶこと
ができる。これらのジペプチドは、溶解性が高ま
るので溶解度が低いアミノ酸、例えばチロシンな
どや細胞による消費の大きいアミノ酸を高濃度で
添加することによつて細胞培養において、必要な
アミノ酸を供給することができる。加えて、これ
らアミノ酸をジペプチドとして供給することによ
つて、細胞の増殖性または、ペプチダーゼ活性に
合わせて細胞に吸収されるので、アミノ酸単体と
して用いるより有効に利用される。
実施例 1
表1に示す加熱殺菌可能なRPMI1640培地(日
水製薬製)10.2gとグリシル−L−グルタミン、
L−グルタミン又はN−アセチル−L−グルタミ
ンを表2に示す濃度となるよう蒸留水1に溶解
し、120℃、15分間オートクレーブにて加熱殺菌
した。別に密栓した培地瓶に入れ、120℃、15分
間加熱殺菌した10%重炭酸ナトリウム液を20ml加
えた後、ウシ胎児血清(FBS)50mlを加えた。
各々の培地100mlを用いてUMCL細胞及びBALL
−1細胞を5×105個/mlの初発細胞濃度となる
ように、ベルコ社製100ml用スピンナーフラスコ
に播き、5%CO2、37℃下、回転数80r.p.m.で
UMCL細胞は4日間、BALL−1細胞は5日間
培養した。培養後各々の細胞密度をエオシンY染
色法と血球計算盤にて生細胞密度を計測した。
[Industrial Application Field] The present invention relates to a medium for culturing animal cells. [Prior Art] Research aimed at culturing animal, especially human cells, and obtaining useful physiologically active substances from the culture supernatant or cells has been active, and interferon (IFN) and other useful substances have been intensified. Remarkable progress has been made in the development of monoclonal antibodies, as they have the potential to prevent and treat cancer. However, there are major technical problems in obtaining a large amount of physiologically active substances from semen through cell culture, purifying them, and utilizing them. One of the problems is that the culture medium must be sterilized by filtration using a filter such as a membrane filter. This sterile filtration method usually
A filter with a pore size of 0.2 to 0.5 mm is used, but this filtration method is difficult to remove microorganisms smaller than bacteria, such as mycoplasma and viruses, which are known to cause problems in animal cell culture. . Also,
Filtration sterilization must be performed under pressure or reduced pressure, and depending on the material of the filter, trace amounts of active ingredients in the culture medium may be adsorbed and lost, or the pressure applied to the membrane or the non-uniformity of the material may for,
It is rare for trace amounts of bacteria to leak out, so
Media prepared by filter sterilization must be subjected to various assays. The above problems are especially serious in large-scale cell culture, and the running costs of membranes and equipment also increase. Heat sterilization can solve these problems. As a method for preparing a medium that can be heat sterilized, a method for preparing a medium that has a pH of 4.0 to 4.5 and can be sterilized by autoclaving is known (Proc.
Soc.EXp.Biol.Med., vol. 127, p. 335, 1968). However, in these media, L-glutamine and sodium bicarbonate cannot be sterilized by heat, and L-glutamine still needs to be sterilized by filtration. L-glutamine derivatives such as L-alanyl-L-glutamine are known to be stable against heat (J. Appl. Biochem. vol. 4, p. 280, 1982). It was unclear whether it would be used. [Problems to be Solved by the Invention] Therefore, an object of the present invention is to find an L-glutamine derivative that is stable against heat and can be used as L-glutamine in animal cells, and to thereby achieve heat sterilization. The objective is to find a culture medium for animal cells that can [Means for solving the problem] Under the circumstances described above, the inventors
It has been found that a medium prepared by autoclaving an aqueous solution of a dipeptide represented by -L-glutamine (X is an L-amino acid) is suitable for culturing animal cells. The medium of the present invention is a medium that is slightly acidic and can be sterilized by heat, such as Eagle MEM medium, Dulbecco's MEN medium.
Remove sodium bicarbonate and L-glutamine from culture medium, RPMI1640 medium, mixed culture thereof, etc.
In addition, XL-glumitan was added. These media also include serum-supplemented media or serum-free media containing serum or various growth factors as serum substitutes. X of the dipeptide represented by XL-glutamine of the present invention is glycine, L or DL-alanine, L-aspartic acid, L-glutamic acid, L-
-valine, L-leucine, L-serine, L-lysine, L-phenylalanine, etc., but glycine, L- or DL-alanine is preferred from the viewpoint of raw material cost. The animal cells used in the present invention include:
For example, WI-38, HeLa, L, UMCL, BALL-
1, X-5563, Molt-4, peripheral blood lymphocytes, various hybridomas, etc. XL-glutamine is originally the L-glutamine that should be added.
Dissolve to the same molar concentration as glutamine (1 to 4mM) and sterilize with normal heat (120℃, 20 minutes)
It is better to do this. In addition, only XL-glutamine is made into an aqueous solution with a concentration 100 to 500 times its added concentration,
It can also be prepared by adding 1/100 to 1/500 of the amount to the culture solution after heat sterilization. All of the low molecular weight medium components can be prepared by heat sterilization by adding a 10% aqueous sodium bicarbonate solution to the medium prepared in this manner so as to have a predetermined amount in the medium after heat sterilization. 〔Effect of the invention. Effect] The animal cell culture medium of the present invention is superior in that all of the low molecular weight medium components can be heat sterilized. Another advantage is that the medium can be stored for a long period of time. Moreover, X of XL-glutamine according to the present invention
can select amino acids that match the needs of the cell. Since these dipeptides have increased solubility, necessary amino acids can be supplied in cell culture by adding high concentrations of amino acids with low solubility, such as tyrosine, or amino acids that are largely consumed by cells. In addition, by supplying these amino acids as dipeptides, they are absorbed into cells in accordance with cell proliferation or peptidase activity, so they are utilized more effectively than when they are used as amino acids alone. Example 1 10.2 g of heat-sterilizable RPMI1640 medium (manufactured by Nissui Pharmaceutical Co., Ltd.) shown in Table 1 and glycyl-L-glutamine,
L-glutamine or N-acetyl-L-glutamine was dissolved in distilled water 1 to the concentration shown in Table 2, and heat sterilized at 120° C. for 15 minutes in an autoclave. Placed in a separately sealed culture medium bottle, 20 ml of 10% sodium bicarbonate solution heat-sterilized at 120°C for 15 minutes was added, and then 50 ml of fetal bovine serum (FBS) was added.
UMCL cells and BALL using 100ml of medium each
-1 cells were seeded in a 100 ml spinner flask manufactured by Belco at an initial cell concentration of 5 x 10 5 cells/ml, and the cells were heated at 5% CO 2 at 37°C and at a rotational speed of 80 rpm.
UMCL cells were cultured for 4 days, and BALL-1 cells were cultured for 5 days. After culturing, each cell density was measured using an eosin Y staining method and a hemocytometer.
【表】【table】
【表】
結果を、通常の濾過滅菌にて調製した10%
FBS添加RPMI1640培地を対照培地として用いた
結果と比べて表2に示す。[Table] The results are 10% prepared by normal filtration sterilization.
Table 2 shows a comparison with the results obtained using FBS-supplemented RPMI1640 medium as a control medium.
【表】
実施例 2
表3に示すRITC57−1培地(L−グルタミン
を含まない)に0.5%ウシ血清アルブミン(BSA)
を添加し、1NNaOH液でPHを7.4に調整した培地
を濾過滅菌にて調製した。この倍地に表4に示し
たL−グルタミン誘導体の濃度の100倍水溶液を
調製し、その一方をミリポア社製0.22μmのメン
ブラン・フイルターで濾過滅菌し、他方を、120
℃、20分間でオートクレーブにて加熱殺菌した
後、上記培地に対して各々1/100量を添加した。
各々の培地20mlを、フアルコン社製3024フラスコ
に入れ、UMCL細胞、BALL−1細胞及びX5563
細胞を各々4×105個/ml、3×105個/ml及び1
×105個/mlの初発濃度となるように加え、5%
CO2、37℃にて各々4日間、5日間、4日間培養
した。培養後の生細胞密度を実施例1と同様に測
定した。結果を表4に示す。[Table] Example 2 0.5% bovine serum albumin (BSA) was added to the RITC57-1 medium (without L-glutamine) shown in Table 3.
was added, and the pH was adjusted to 7.4 with 1N NaOH solution, and a medium was prepared by filter sterilization. In this medium, an aqueous solution 100 times the concentration of the L-glutamine derivative shown in Table 4 was prepared, one of which was sterilized by filtration using a 0.22 μm membrane filter manufactured by Millipore, and the other was
After heat sterilization in an autoclave at ℃ for 20 minutes, 1/100 amount of each was added to the above medium.
Put 20 ml of each medium into a 3024 flask made by Falcon, and add 20 ml of each medium to UMCL cells, BALL-1 cells and X5563 cells.
4 x 10 cells/ml, 3 x 10 cells/ml and 1 cell, respectively.
x10 to give an initial concentration of 5 cells/ml, and 5%
The cells were cultured for 4 days, 5 days, and 4 days under CO 2 and 37°C, respectively. The viable cell density after culturing was measured in the same manner as in Example 1. The results are shown in Table 4.
【表】【table】
【表】
ウム
HEPES 1200
[Table] Umu
HEPES 1200
【表】【table】
Claims (1)
る)で表わされるジペプチドを含有する動物細胞
を培養するための培地。1 A medium for culturing animal cells containing a dipeptide represented by XL-glutamine (X is an L-amino acid).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60112285A JPS61271985A (en) | 1985-05-27 | 1985-05-27 | Culture medium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60112285A JPS61271985A (en) | 1985-05-27 | 1985-05-27 | Culture medium |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61271985A JPS61271985A (en) | 1986-12-02 |
JPS6338190B2 true JPS6338190B2 (en) | 1988-07-28 |
Family
ID=14582864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60112285A Granted JPS61271985A (en) | 1985-05-27 | 1985-05-27 | Culture medium |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61271985A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2610338A4 (en) | 2010-08-02 | 2015-03-25 | Kyowa Hakko Kirin Co Ltd | Method for producing substance |
DE102017203908B3 (en) | 2017-03-09 | 2018-05-30 | Evonik Technochemie Gmbh | Culture medium comprising oligopeptides |
PL3372670T3 (en) | 2017-03-09 | 2019-08-30 | Evonik Technochemie Gmbh | Culture media comprising n-acyl-x-glutamine dipeptides |
-
1985
- 1985-05-27 JP JP60112285A patent/JPS61271985A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS61271985A (en) | 1986-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE871414L (en) | Preparation of lymphokine activated killer cells. | |
Bader et al. | LATENT VIRAL INFECTION OF CELLS IN TISSUE CULTURE: VI. Role of Amino Acids, Glutamine, and Glucose in Psittacosis Virus Propagation in L Cells | |
Minamoto et al. | Development of a serum-free and heat-sterilizable medium and continuous high-density cell culture | |
EP0759029A1 (en) | Modified milk growth factor | |
Baker et al. | Effect of the amino acids and dialyzable constituents of embryonic tissue juice on the growth of fibroblasts | |
JPS6338190B2 (en) | ||
CN110101864A (en) | The protective agent of serum-free Antirabic Vaccine a kind of and its application | |
Palotie et al. | Effect of the structural components of basement membranes on the attachment of teratocarcinoma-derived endodermal cells | |
EP0396402A2 (en) | Cell growth activators | |
JP2004135672A (en) | Composition comprising polyethylene glycol for culturing animal cells or tissue cells | |
JP2850430B2 (en) | Serum-free medium for cell culture | |
JPS6326988B2 (en) | ||
JPH0947284A (en) | Cultivation of animal cell | |
Ito et al. | The growth-stimulating activity of peptides on human hematopoietic cell cultures | |
JPS6030508B2 (en) | Cell culture container | |
RU2066995C1 (en) | Method of preparing preparation stimulating cellular respiration | |
JPS63188697A (en) | Cell growth promoting substance extracted from bovine spleen, extraction thereof and inactivation treatment of virus | |
JPS6087785A (en) | Preparation and sterilization of serum-free medium for animal cell | |
Oberley et al. | The growth of primary glomerular cells as a confluent monolayer in a chemically defined serum-free medium: specific requirements for prostaglandins and extracellular matrix molecules. | |
JPH03201981A (en) | Preparation of serum-free medium for cell culture | |
WO2003097819A1 (en) | Cell culture method using marine deep water | |
CN113693957A (en) | Complete cosmetic culture medium liquid preparation for skin cell proliferation growth and repair and preparation method thereof | |
CN105255812A (en) | Low-serum culture medium suitable for BHK-21 cell spinner flask culture and preparation method thereof | |
JPS63188698A (en) | Cell growth promoting substance extracted from bovine thymus, extraction thereof and inactivation treatment of virus | |
AU645589B2 (en) | Growth-promoting agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |